Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial

DiscussionThe SNUG is a clinical study that aims to investigate the antipruritic effect of PG102P to ameliorate itching in patients undergoing hemodialysis.Trial registrationClinical,NCT03576235. Registered on 4 July 2018.
Source: Trials - Category: Research Source Type: clinical trials